Some states may wait a year to expand Medicaid | Colo. embraces expansion of Medicaid eligibility | Mass. governor proposes stricter oversight of drug compounders
Web Version
 
 
January 7, 2013
FOLLOW PCMA ON TWITTER  Twitter
PCMA SmartBrief
News for the PBM Industry
SIGN UP|FORWARD|ARCHIVE

Featured Story
Some states may wait a year to expand Medicaid
The federal government will cover most of the costs for states to expand Medicaid coverage under the Affordable Care Act, but states that expand will nonetheless incur costs, and some may wait a year or longer before expanding their programs. Politico (Washington, D.C.) (5/7)
Share: LinkedInTwitterFacebookGoogle+Email
Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
Advertisement
 
Legislative & Regulatory News
Colo. embraces expansion of Medicaid eligibility
Colorado will expand its Medicaid program, Democratic Gov. John Hickenlooper said, and the state has won conditional approval to run a health insurance exchange under the Affordable Care Act. The Hill/Healthwatch blog (1/4)
Share: LinkedInTwitterFacebookGoogle+Email
Mass. governor proposes stricter oversight of drug compounders
Massachusetts Gov. Deval Patrick proposed developing special licensing requirements for compounding pharmacies, requiring out-of-state compounders to be licensed by the state if they ship products into Massachusetts and giving the state Board of Pharmacy authority to issue fines to companies that break its rules. Reuters (1/4), Modern Healthcare (free registration)/The Associated Press (1/4)
Share: LinkedInTwitterFacebookGoogle+Email
Drug Industry Spotlight
Indian high court could decide drug patent case in early 2013
India's Supreme Court is expected to rule early this year on whether domestic drugmakers can continue to offer generic versions of some treatments. Aid groups argue that the country plays an important role in providing drugs for the poor, while drugmakers emphasize the need for strong patent protection to facilitate the development of drugs. The Washington Times/The Associated Press (1/4)
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
If money be not thy servant, it will be thy master. The covetous man cannot so properly be said to possess wealth, as that may be said to possess him."
-- Francis Bacon,
British author and statesman
Share: LinkedInTwitterFacebookGoogle+Email
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 216 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
(202) 207-3610
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Melissa Turner
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information